Italian-style coffee reduces the risk of prostate cancer

April 26, 2017, Istituto Neurologico Mediterraneo Neuromed I.R.C.C.S.
Credit: George Hodan/public domain

Add another typical component of the Italian way of life to the long list of foods characterizing one of the most healthy populations in the world. This time it's coffee, prepared the Italian way. A research by the Department of Epidemiology and Prevention - I.R.C.C.S. Neuromed, Italy, in collaboration with the Italian National Institute of Health and the I.R.C.C.S. Istituto Dermopatico dell'Immacolata of Rome, shows that three or more cups a day can lower prostate cancer risk. An antitumor action confirmed also by laboratory experiments.

The study, published in the International Journal of Cancer, sheds light in a field still hotly debated to this day: the role of coffee, and specifically caffeine, in relation to . A protective effect of the popular drink has already been suggested by some recent studies.

"In recent years we have seen a number of international studies on this issue," explains George Pounis, researcher at Neuromed and first author of the paper. "But scientific evidence has been considered insufficient to draw conclusions. Moreover, in some cases, results were contradictory. Our goal, therefore, was to increase knowledge in this field and to provide a clearer view."

About 7,000 men of the Molise region who participated in the epidemiological study were observed for four years on average. "By analyzing their coffee consumption habits," explains Pounis, "and comparing them with prostate cases occurring over time, we saw a net reduction of risk, 53 percent, in those who drank more than three cups a day."

Then researchers sought confirmation by testing the action of coffee extracts on in laboratory studies. They tested both caffeinated and decaffeinated varieties. Only caffeinated coffee extracts significantly reduced cancer cell proliferation and metastasization. This effect was not observed with decaf.

Maria Benedetta Donati, head of the Laboratory of Translational Medicine, says, "The observations on cancer cells allow us to say that the beneficial effect observed among the 7,000 participants is most likely due to caffeine, rather than to the many other substances contained in coffee."

Licia Iacoviello, head of the Molecular and Nutritional Epidemiology Laboratory, says, "We should keep in mind that the study is conducted on a central Italian population. They prepare rigorously, the Italian way: high pressure, very high water temperature and with no filters. This method, different from those followed in other areas of the world, could lead to a higher concentration of bioactive substances. It will be very interesting, now, to explore this aspect. Coffee is an integral part of Italian lifestyle, which, we must remember, is not made just by individual foods, but also by the specific way they are prepared."

Explore further: Coffee may reduce risk of lethal prostate cancer in men

More information: George Pounis et al, Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models, International Journal of Cancer (2017). DOI: 10.1002/ijc.30720

Related Stories

Coffee may reduce risk of lethal prostate cancer in men

May 17, 2011
Men who regularly drink coffee appear to have a lower risk of developing a lethal form of prostate cancer, according to a new study led by Harvard School of Public Health (HSPH) researchers. What's more, the lower risk was ...

Coffee may protect against endometrial cancer

November 22, 2011
Long-term coffee consumption may be associated with a reduced risk for endometrial cancer, according to a recent study in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Coffee drinking habits can be written in our DNA, study finds

August 25, 2016
Researchers have identified a gene that appears to curb coffee consumption.

Caffeinated coffee may reduce the risk of oral cancers

December 10, 2012
A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality. The authors say people who drank more than four cups of caffeinated coffee per ...

Drinking decaf coffee maybe good for the liver

October 9, 2014
Researchers from the National Cancer Institute report that decaffeinated coffee drinking may benefit liver health. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver ...

Coffee consumption linked with reduced risk of diabetes

February 17, 2014
(HealthDay)—Higher consumption of coffee is associated with lower risk of type 2 diabetes, according to research published in the February issue of Diabetes Care.

Recommended for you

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Removing the enablers: Reducing number of tumor-supporting cells to fight neuroblastoma

April 24, 2018
Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune cell—can negatively ...

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

New test could tell doctors whether patients will respond to chemotherapy

April 24, 2018
Less than half the patients diagnosed with cancer respond favorably to chemotherapy, but a new method for testing how patients will respond to various drugs could pave the way for more personalized treatment.

Vitamin A derivative selectively kills liver cancer stem cells

April 23, 2018
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer. Now, in research published in Proceedings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.